tradingkey.logo

Firefly Neuroscience Inc

AIFF
1.580USD
+0.070+4.64%
Close 11/21, 16:00ETQuotes delayed by 15 min
21.29MMarket Cap
LossP/E TTM

Firefly Neuroscience Inc

1.580
+0.070+4.64%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Firefly Neuroscience Inc

Currency: USD Updated: 2025-11-21

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Firefly Neuroscience Inc's Score

Industry at a Glance

Industry Ranking
245 / 484
Overall Ranking
467 / 4593
Industry
Software & IT Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Firefly Neuroscience Inc Highlights

StrengthsRisks
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Growing
The company is in a growing phase, with the latest annual income totaling USD 108.00K.
Fairly Valued
The company’s latest PE is -0.70, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.85M shares, increasing 42.61% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 503.07K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.22.

Financial Health

Currency: USD Updated: 2025-11-21

The company's current financial score is 6.16, which is lower than the Software & IT Services industry's average of 7.26. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 388.00K, representing a year-over-year increase of 1075.76%, while its net profit experienced a year-over-year increase of 38.47%.

Score

Industry at a Glance

Previous score
6.16
Change
0

Financials

9.37

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.30

Operational Efficiency

2.57

Growth Potential

3.43

Shareholder Returns

7.11

Firefly Neuroscience Inc's Company Valuation

Currency: USD Updated: 2025-11-21

The company’s current valuation score is 8.18, which is higher than the Software & IT Services industry's average of 7.30. Its current P/E ratio is -0.70, which is -69.92% below the recent high of -0.21 and -1285.28% above the recent low of -9.68.

Score

Industry at a Glance

Previous score
8.18
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 245/484
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-11-21

There is no earnings forecast score for this company; the Software & IT Services industry's average is 7.59.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-21

The company’s current price momentum score is 4.01, which is lower than the Software & IT Services industry's average of 6.68. Sideways: Currently, the stock price is trading between the resistance level at 1.98 and the support level at 1.32, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
3.95
Change
0.06

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.049
Neutral
RSI(14)
36.058
Neutral
STOCH(KDJ)(9,3,3)
30.732
Neutral
ATR(14)
0.144
Low Volatility
CCI(14)
-70.479
Neutral
Williams %R
63.959
Sell
TRIX(12,20)
-1.837
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.558
Buy
MA10
1.588
Sell
MA20
1.699
Sell
MA50
2.331
Sell
MA100
2.569
Sell
MA200
3.293
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-21

The company’s current institutional recognition score is 3.00, which is lower than the Software & IT Services industry's average of 5.79. The latest institutional shareholding proportion is 13.77%, representing a quarter-over-quarter decrease of 71.97%. The largest institutional shareholder is The Vanguard, holding a total of 503.07K shares, representing 3.73% of shares outstanding, with 382.20% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Johnson (David Ian)
1.12M
+100.00%
Windsor Private Capital LP
1.71M
+12.01%
The Vanguard Group, Inc.
Star Investors
101.99K
--
RJL 18 Capital Canada LP
499.37K
--
Lipschitz (Gregory)
431.20K
+2.62%
Roxy Capital Corp.
424.69K
-38.46%
Finn (Christopher)
349.22K
-19.76%
Geode Capital Management, L.L.C.
120.60K
+92.85%
Menawat (Arun Swarup Ph.D.)
99.41K
--
BlackRock Institutional Trust Company, N.A.
14.44K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-11-21

The company’s current risk assessment score is 2.27, which is lower than the Software & IT Services industry's average of 4.90. The company's beta value is 1.91. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.27
Change
0
Beta vs S&P 500 index
1.91
VaR
+11.71%
240-Day Maximum Drawdown
+90.49%
240-Day Volatility
+177.35%

Return

Best Daily Return
60 days
+9.40%
120 days
+10.86%
5 years
+170.97%
Worst Daily Return
60 days
-13.62%
120 days
-13.62%
5 years
-41.72%
Sharpe Ratio
60 days
-2.72
120 days
-1.95
5 years
+0.20

Risk Assessment

Maximum Drawdown
240 days
+90.49%
3 years
+96.08%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.55
3 years
-0.31
5 years
--
Skewness
240 days
+8.45
3 years
+5.74
5 years
+6.01

Volatility

Realised Volatility
240 days
+177.35%
5 years
--
Standardised True Range
240 days
+27.14%
5 years
--
Downside Risk-Adjusted Return
120 days
-275.23%
240 days
-275.23%
Maximum Daily Upside Volatility
60 days
+42.27%
Maximum Daily Downside Volatility
60 days
+53.27%

Liquidity

Average Turnover Rate
60 days
+24.56%
120 days
+17.80%
5 years
--
Turnover Deviation
20 days
+21.82%
60 days
-30.99%
120 days
-49.98%

Peer Comparison

Software & IT Services
Firefly Neuroscience Inc
Firefly Neuroscience Inc
AIFF
4.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ePlus inc
ePlus inc
PLUS
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cognizant Technology Solutions Corp
Cognizant Technology Solutions Corp
CTSH
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
Amdocs Ltd
DOX
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Akamai Technologies Inc
Akamai Technologies Inc
AKAM
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Clearwater Analytics Holdings Inc
Clearwater Analytics Holdings Inc
CWAN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Firefly Neuroscience Inc?

The TradingKey Stock Score provides a comprehensive assessment of Firefly Neuroscience Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Firefly Neuroscience Inc’s performance and outlook.

How do we generate the financial health score of Firefly Neuroscience Inc?

To generate the financial health score of Firefly Neuroscience Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Firefly Neuroscience Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Firefly Neuroscience Inc.

How do we generate the company valuation score of Firefly Neuroscience Inc?

To generate the company valuation score of Firefly Neuroscience Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Firefly Neuroscience Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Firefly Neuroscience Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Firefly Neuroscience Inc.

How do we generate the earnings forecast score of Firefly Neuroscience Inc?

To calculate the earnings forecast score of Firefly Neuroscience Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Firefly Neuroscience Inc’s future.

How do we generate the price momentum score of Firefly Neuroscience Inc?

When generating the price momentum score for Firefly Neuroscience Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Firefly Neuroscience Inc’s prices. A higher score indicates a more stable short-term price trend for Firefly Neuroscience Inc.

How do we generate the institutional confidence score of Firefly Neuroscience Inc?

To generate the institutional confidence score of Firefly Neuroscience Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Firefly Neuroscience Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Firefly Neuroscience Inc.

How do we generate the risk management score of Firefly Neuroscience Inc?

To assess the risk management score of Firefly Neuroscience Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Firefly Neuroscience Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Firefly Neuroscience Inc.
KeyAI